Israel Englander Myriad Genetics Inc Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $3.42 Million - $4.84 Million	-190,000 Reduced 86.36%	30,000 $733,000
Q1 2024 May 15, 2024	BUY	$17.59 - $23.59 $2.11 Million - $2.83 Million	120,000 Added 120.0%	220,000 $4.69 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $1.39 Million - $2.13 Million	100,000 New	100,000 $1.91 Million
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $311,304 - $484,500	20,400 New	20,400 $474,000
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $2.21 Million - $3.39 Million	-121,500 Reduced 85.68%	20,300 $387,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.